Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.
Dongiovanni V, Buffoni L, Berruti A, Dongiovanni D, Grillo R, Barone C, Addeo A, Fissore C, Bertetto O. Dongiovanni V, et al. Among authors: buffoni l. Cancer Chemother Pharmacol. 2006 Aug;58(2):203-9. doi: 10.1007/s00280-005-0157-6. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331497 Clinical Trial.
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
Brunelli M, Gobbo S, Malpeli G, Sirgiovanni G, Caserta C, Munari E, Francesconi S, Caliò A, Martignoni G, Cimadamore A, Veccia A, Antonelli A, Tucci M, Pierconti F, Hattab IM, Eccher A, Ascani S, Milella M, Buffoni L, Cheng L, Bracarda S. Brunelli M, et al. Among authors: buffoni l. Pathologica. 2024 Feb;116(1):55-61. doi: 10.32074/1591-951X-937. Pathologica. 2024. PMID: 38482675 Free PMC article.
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.
Dongiovanni D, Fissore C, Berruti A, Buffoni L, Addeo A, Barone C, Polimeni MA, Ottaviani D, Bertetto O, Dongiovanni V. Dongiovanni D, et al. Among authors: buffoni l. Lung Cancer. 2005 Feb;47(2):269-75. doi: 10.1016/j.lungcan.2004.06.019. Lung Cancer. 2005. PMID: 15639726 Clinical Trial.
Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
Dongiovanni D, Daniele L, Barone C, Dongiovanni V, Fissore C, Sapino A, Macrì L, Bussolati G, Buffoni L, Gaspari F, Grillo R, Birocco N, Addeo A, Ciuffreda L, Schena M. Dongiovanni D, et al. Among authors: buffoni l. Lung Cancer. 2008 Jul;61(1):73-81. doi: 10.1016/j.lungcan.2007.12.007. Epub 2008 Feb 19. Lung Cancer. 2008. PMID: 18243402 Clinical Trial.
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M. Barone C, et al. Among authors: buffoni l. Anticancer Res. 2008 Mar-Apr;28(2B):1285-91. Anticancer Res. 2008. PMID: 18505067 Free article. Clinical Trial.
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario.
Addeo A, Tabbò F, Robinson T, Buffoni L, Novello S. Addeo A, et al. Among authors: buffoni l. Crit Rev Oncol Hematol. 2018 Feb;122:150-156. doi: 10.1016/j.critrevonc.2017.12.015. Epub 2017 Dec 30. Crit Rev Oncol Hematol. 2018. PMID: 29458783 Free article. Review.
138 results